Chemours Co Stock Buy Hold or Sell Recommendation
| CC Stock | USD 26.43 0.52 2.01% |
Allowing for the 90-day total investment horizon and your above-average risk tolerance, our recommendation regarding Chemours Co is 'Strong Sell'. Macroaxis provides Chemours buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Chemours positions. The advice algorithm takes into account all of Chemours' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Chemours' buy or sell advice are summarized below:
Real Value 29.74 | Target Price 37.89 | Hype Value 25.8 | Market Value 26.43 | Naive Value 25 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Chemours Co given historical horizon and risk tolerance towards Chemours. When Macroaxis issues a 'buy' or 'sell' recommendation for Chemours Co, the advice is generated through an automated system that utilizes algorithms and statistical models.
Chemours |
Execute Chemours Buy or Sell Advice
The Chemours recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Chemours Co. Macroaxis does not own or have any residual interests in Chemours Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Chemours' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Chemours Trading Alerts and Improvement Suggestions
| Chemours generated a negative expected return over the last 90 days | |
| Chemours has high historical volatility and very poor performance | |
| The company generated the yearly revenue of 6.03 B. Annual Net Loss to common stockholders was (238 M) with gross profit of 1.62 B. | |
| Chemours has a strong financial position based on the latest SEC filings | |
| Over 78.0% of the company shares are held by institutions such as insurance companies | |
| On 15th of March 2024 Chemours paid $ 0.25 per share dividend to its current shareholders | |
| Latest headline from benzinga.com: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Secure Counsel Before Important Deadline in Securities Class Action CC |
Chemours Returns Distribution Density
The distribution of Chemours' historical returns is an attempt to chart the uncertainty of Chemours' future price movements. The chart of the probability distribution of Chemours daily returns describes the distribution of returns around its average expected value. We use Chemours Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Chemours returns is essential to provide solid investment advice for Chemours.
| Mean Return | 0.02 | Value At Risk | -5.01 | Potential Upside | 7.41 | Standard Deviation | 5.52 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Chemours historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Chemours Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Chemours is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chemours Co backward and forwards among themselves. Chemours' institutional investor refers to the entity that pools money to purchase Chemours' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2023-12-31 | 2.3 M | American Century Companies Inc | 2023-12-31 | 1.4 M | Vaughan Nelson Scarbrgh & Mccullough Lp | 2023-12-31 | 1.4 M | Goldman Sachs Group Inc | 2023-12-31 | 1.3 M | Norges Bank | 2023-12-31 | 1.2 M | Charles Schwab Investment Management Inc | 2023-12-31 | 1.1 M | Northern Trust Corp | 2023-12-31 | 1.1 M | Legal & General Group Plc | 2023-12-31 | 1.1 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1 M | Blackrock Inc | 2023-12-31 | 16.5 M | Fmr Inc | 2023-12-31 | 16.4 M |
Chemours Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 116M | 126M | (202M) | (390M) | 58M | 60.9M | |
| Free Cash Flow | 169M | 540M | 543M | 447M | 186M | 309.8M | |
| Depreciation | 311M | 320M | 317M | 291M | 307M | 313.9M | |
| Other Non Cash Items | 399M | 16M | (89M) | (58M) | 7M | 6.7M | |
| Capital Expenditures | 481M | 267M | 277M | 307M | 370M | 326.0M | |
| Net Income | (52M) | 219M | 608M | 578M | (238M) | (226.1M) | |
| Investments | (2M) | 27M | (12M) | 3M | (229M) | (217.6M) | |
| Change In Cash | (258M) | 162M | 446M | (247M) | 705M | 740.3M | |
| Net Borrowings | 128M | (136M) | (29M) | (1M) | (900K) | (855K) | |
| Change To Netincome | 263M | (76M) | (124M) | (10M) | (11.5M) | (12.1M) | |
| Change Receivables | 191M | 175M | (225M) | 91M | 104.7M | 109.9M | |
| End Period Cash Flow | 943M | 1.1B | 1.6B | 1.3B | 1.8B | 1.3B |
Chemours Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Chemours or Chemicals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Chemours' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Chemours stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.09 | |
β | Beta against NYSE Composite | 1.40 | |
σ | Overall volatility | 5.55 | |
Ir | Information ratio | -0.01 |
Chemours Volatility Alert
Chemours Co exhibits above-average semi-deviation for your current time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Chemours' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Chemours' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Chemours Implied Volatility
Chemours' implied volatility exposes the market's sentiment of Chemours Co stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Chemours' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Chemours stock will not fluctuate a lot when Chemours' options are near their expiration.
Chemours Fundamentals Vs Peers
Comparing Chemours' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Chemours' direct or indirect competition across all of the common fundamentals between Chemours and the related equities. This way, we can detect undervalued stocks with similar characteristics as Chemours or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Chemours' fundamental indicators could also be used in its relative valuation, which is a method of valuing Chemours by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Chemours to competition |
| Fundamentals | Chemours | Peer Average |
| Return On Equity | -0.26 | -0.31 |
| Return On Asset | 0.0529 | -0.14 |
| Profit Margin | (0.04) % | (1.27) % |
| Operating Margin | 0.07 % | (5.51) % |
| Current Valuation | 6.95 B | 16.62 B |
| Shares Outstanding | 148.88 M | 571.82 M |
| Shares Owned By Insiders | 0.59 % | 10.09 % |
| Shares Owned By Institutions | 77.71 % | 39.21 % |
| Number Of Shares Shorted | 4.88 M | 4.71 M |
| Price To Earning | 25.49 X | 28.72 X |
| Price To Book | 5.35 X | 9.51 X |
| Price To Sales | 0.65 X | 11.42 X |
| Revenue | 6.03 B | 9.43 B |
| Gross Profit | 1.62 B | 27.38 B |
| EBITDA | 220 M | 3.9 B |
| Net Income | (238 M) | 570.98 M |
| Cash And Equivalents | 1.1 B | 2.7 B |
| Cash Per Share | 7.73 X | 5.01 X |
| Total Debt | 4.3 B | 5.32 B |
| Debt To Equity | 2.94 % | 48.70 % |
| Current Ratio | 1.82 X | 2.16 X |
| Book Value Per Share | 4.96 X | 1.93 K |
| Cash Flow From Operations | 556 M | 971.22 M |
| Short Ratio | 1.37 X | 4.00 X |
| Earnings Per Share | (1.60) X | 3.12 X |
| Price To Earnings To Growth | 1.67 X | 4.89 X |
| Target Price | 31.44 | |
| Number Of Employees | 6.2 K | 18.84 K |
| Beta | 2.02 | -0.15 |
| Market Capitalization | 3.86 B | 19.03 B |
| Total Asset | 8.25 B | 29.47 B |
| Retained Earnings | 1.78 B | 9.33 B |
| Working Capital | 1.35 B | 1.48 B |
Note: Acquisition by Camela Wisel of 5425 shares of Chemours subject to Rule 16b-3 [view details]
Chemours Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Chemours . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 27226.83 | |||
| Daily Balance Of Power | 0.7429 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 26.36 | |||
| Day Typical Price | 26.38 | |||
| Price Action Indicator | 0.33 | |||
| Period Momentum Indicator | 0.52 |
About Chemours Buy or Sell Advice
When is the right time to buy or sell Chemours Co? Buying financial instruments such as Chemours Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 668M | 554M | 1.2B | 1.3B | Total Assets | 7.6B | 7.6B | 8.3B | 7.5B |
Use Investing Ideas to Build Portfolios
In addition to having Chemours in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Non-Metallic and Industrial Metal Mining Thematic Idea Now
Non-Metallic and Industrial Metal Mining
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Non-Metallic and Industrial Metal Mining theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Non-Metallic and Industrial Metal Mining Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Chemours Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (1.60) | Revenue Per Share 40.473 | Quarterly Revenue Growth 0.017 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.